Search
for
Sort by
Research 931–960 of 1000+
- Issues in the Treatment of Epilepsy
- Dermatologic Adverse Events from Cancer Treatments
- The Novel Excipient, Dodecyl-2-N, N-dimethylaminopropionate Hydrochloride (DDAIP-HCl) Improves the Flux of Minoxidil in Human Skin
- COSMECEUTICALS: THE BIOACTIVE ELEMENTS IN NEW-AGE BEAUTY PRODUCTS
- Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions
- Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity
- Consumer Acceptance and Market Potential of Natural Organic Cosmetic Formulations in the US Market
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Potencial de nanopartículas poliméricas de Delonix contendo isotretinoína para o tratamento da acne
- 571 Role of observation for excisionally biopsied moderately dysplastic nevi with positive histologic margins and risk of development of future melanoma
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Prostaglandin-Induced Hair Growth
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Wound Healing: A Cellular Perspective
- Transforming growth factor-β in stem cells and tissue homeostasis
- Molecular mechanisms of androgenetic alopecia
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Hormone therapy for transgender patients
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues